Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-25T04:31:30.342Z Has data issue: false hasContentIssue false

Development of medical Care Technology: The Case of Israel

Published online by Cambridge University Press:  10 March 2009

Avi Y. Ellencweig
Affiliation:
Hebrew University

Abstract

This article presents a survey of the public and private agencies and institutions providing health care in Israel and examines the degree and nature of the control that these bodies exercise over medical technology. The author demonstrates that while the Israeli government is highly centralized, the Ministry of Health is able to exercise only limited practical influence and is neutralized because of its circumscribed control of government funds. In addition, the Ministry of Health lacks standardized procedures for the assessment of prospective or existing technologies. The author notes that there has been a clear move toward a system to oversee the rational diffusion of technology and outlines several proposals for the future.

Type
Special Section: Health Care Systems and the Diffusion of Technology, Part I
Copyright
Copyright © Cambridge University Press 1988

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Banta, H. D., & Russell, L. B. Summary and Analysis. In Banta, H. D. & Kemp, K. B. (eds.), The management of health care technologies in nine countries. New York: Springer, 1982.Google ScholarPubMed
Corten, E. D., & Abramson, J. H.Health technology assessment. Israel Journal of Medical Sciences, 1986, 22, 166168.Google Scholar
Egoz, N.Cost-benefit of mass prophylaxis with immune serum globulin to control waterborne hepatitis A. A case study. Israel Journal of Medical Sciences, 1986, 22, 277–82.Google ScholarPubMed
Ellencweig, A. Y.The new Israeli health care reform – an analysis of a national need. Journal of Health Policy, Politics and Law, 1983, 8, 366386.Google ScholarPubMed
Ellencweig, A. Y.Modern dilemmas in health care–the Israeli doctor's strike. Industrial Relations Journal, 1987, 18, 117129.CrossRefGoogle Scholar
Frenkel, D. A.Human experimentation: Code of ethics. Legal Medical Quarterly, 1977, 1, 714 (appendix D).Google Scholar
Frenkel, D. A.Legal aspects of clinical trials in Israel. Israel Journal of Medical Sciences, 1983, 19, 452457.Google ScholarPubMed
Government of Israel. Budget Proposal 1986. Jerusalem: Ministry of Finance, 1986.Google Scholar
Grushka, T.Health services in Israel. Jerusalem: Ministry of Health, 1968.Google Scholar
Halevi, H. S.The bumpy road to national health insurance– the case of Israel. Jerusalem: Joint Israel-Brookdale Institute of Gerontology, 1980.Google Scholar
Kop, Y., Blankett, J., & Sharon, D. Government expenditure on social services. In Kop, Y. (ed.), Changing social policy–Israel 1985–1986. Jerusalem: The Center for Social Policy Studies in Israel, 1986, pp. 9899.Google Scholar
Legum, C., Shomrat, R., Yedwab, G., Jaffa, A. J., & Rudick, A.Early pregnancy screening for neural tube defects in Israel. Israel Journal of Medical Sciences, 1986, 22, 210214.Google ScholarPubMed
Maayan and others vs. the Director-General of the Ministry of Health, 1982, H.C. 30/82, 36(2) P.D. 477484.Google Scholar
Peleg, L., Slor, H., Cordova, T., Ayalon, D., Legum, C., & Rudick, A.Improved reliability of a serum alpha fetoprotein enzyme immunoassay compound with a radioimmunoassay. Israel Journal of Medical Sciences, 1986, 22, 215219.Google Scholar
Shani, M.Health technology: The Israeli perspective. Israel Journal of Medical Sciences, 1986, 22, 169172.Google ScholarPubMed
Slavin, S. et al. , New approaches for the prevention of rejection and graft vs. host disease in clinical bone marrow transplantation. Israel Journal of Medical Sciences, 1986, 22, 264267.Google ScholarPubMed